CHLAMYDIA trachomatis infections are common in sexually active adolescents and young adults in the United States (CDC, unpublished review). More than 4 million chlamydial infections occur annually. Infection by this organism is insidious—symptoms are absent or minor among most infected women and many men. This large group of asymptomatic and infectious persons sustains transmission within a community. In addition, these persons are at risk for acute illness and serious long-term sequelae. The direct and indirect costs of chlamydial illness exceed $2.4 billion annually.*
Until recently, chlamydia prevention and patient care were impeded by the lack of suitable laboratory tests for screening and diagnosis. Such tests are now available. Through education, screening, partner referral, and proper patient care, public health workers and health-care practitioners can combine efforts to decrease the morbidity and costs resulting from this infection.
Recommendations for the treatment of genital chlamydial infections have been published (146, 156).
Recommendations for the Management of Chlamydia trachomatis Infections, 1993. Arch Dermatol. 1994;130(3):288. doi:10.1001/archderm.1994.01690030018002